JXSB2000014 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-17 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-09-16 | view |
JXSB2000015 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-17 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-09-16 | view |
JXSB2100016 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-02-27 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-02-26 | view |
JXSB2100023 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXSB2100024 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXSB2100025 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXSB2101032 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-07-13 | | Eli Lilly & Company | | | view |
JXSB2101033 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-07-13 | | Eli Lilly & Company | | | view |
JXSB2101034 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-07-13 | | Eli Lilly & Company | | | view |
JXSB2101069 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-10-21 | | Eli Lilly & Company | | | view |
JXSB2101070 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-10-21 | | Eli Lilly & Company | | | view |
JXSB2101109 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-12-16 | | Eli Lilly & Company | | | view |
JXSB2101110 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-12-16 | | Eli Lilly & Company | | | view |
JXSB2101111 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-12-16 | | Eli Lilly & Company | | | view |
JXSB2200082 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
JXSB2200083 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
JXSB2200084 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
JXSB2200108 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |
JXSB2200109 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |
JXSB2200110 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |